Australia is currently grappling with significant shortages of ADHD medications, particularly those containing methylphenidate hydrochloride, such as Concerta, Ritalin LA, Rubifen LA, and Teva-XR. These shortages are expected to persist until at least the end of 2025, with some products anticipated to be scarce into 2026.
Read more: Key Medications Affected
For the most current information on medication availability, you can visit the TGA’s medicine shortages database here.